What is the normal anion gap and how does it change in diabetic ketoacidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Anion Gap and Changes in Diabetic Ketoacidosis

The normal anion gap is approximately 12 mEq/L or less, and in diabetic ketoacidosis (DKA), it becomes elevated (typically >12 mEq/L) due to accumulation of unmeasured ketone anions, then normalizes during treatment while a hyperchloremic non-anion gap acidosis often develops. 1

Normal Anion Gap Values

  • The normal anion gap is ≤12 mEq/L 1
  • The anion gap represents the difference between measured cations (primarily sodium) and measured anions (chloride and bicarbonate), reflecting "unmeasured" anions in the blood 2
  • Non-carbonate buffers (albumin and phosphate) and plasma pH also contribute to the anion gap calculation 3

Anion Gap Changes in DKA

At Presentation

  • DKA presents with an elevated anion gap metabolic acidosis where the increase in anion gap closely matches the decrease in serum bicarbonate 4
  • The elevated anion gap results from accumulation of ketone bodies (β-hydroxybutyrate and acetoacetate), which are unmeasured anions 1
  • At admission, patients typically have normochloremic acidosis with the increased anion gap exactly balancing the decreased serum bicarbonate 4
  • Blood urea nitrogen elevation increases the anion gap by approximately 0.24 mEq/L per mg/dL increase 5

During Treatment

  • The anion gap normalizes earlier than bicarbonate levels during DKA treatment 6, 7
  • As ketone bodies are metabolized and excreted in urine as sodium and potassium salts during osmotic diuresis, the anion gap closes 4
  • β-hydroxybutyrate (the predominant ketone in DKA) is converted to acetoacetate during therapy, which can falsely suggest worsening ketosis when using nitroprusside methods 1

Development of Hyperchloremic Acidosis

  • After treatment, DKA commonly transitions to hyperchloremic (normal anion gap) metabolic acidosis 4, 7
  • This occurs because excessive saline administration provides chloride that replaces the excreted ketone anions 1
  • Hyperchloremic metabolic acidosis develops in approximately 69% of patients during treatment, typically appearing around 6 hours into therapy 7
  • Patients with hyperchloremic acidosis may have prolonged recovery times despite resolution of ketonemia 6, 7

Clinical Monitoring Implications

Resolution Criteria

  • DKA resolution is defined as: glucose <200 mg/dL, serum bicarbonate ≥18 mEq/L, venous pH >7.3, and anion gap ≤12 mEq/L 1
  • The anion gap should be monitored every 2-4 hours along with venous pH to track resolution of acidosis 1
  • Venous pH is usually 0.03 units lower than arterial pH and is adequate for monitoring 1

Important Caveats

  • Do not rely solely on anion gap normalization for insulin transition decisions 8
  • Patients with normalized anion gap but bicarbonate ≤16 mEq/L have significantly increased odds of transition failure (OR 4.74) 8
  • Monitor β-hydroxybutyrate directly rather than using nitroprusside methods, as the latter do not measure β-hydroxybutyrate and can be misleading during treatment 1
  • The wide prediction interval (±8 mEq/L) for detecting mixed acid-base disorders limits the anion gap's screening utility in DKA 5
  • Monitoring chloride-corrected bicarbonate and non-chloride base deficit can help differentiate ongoing DKA from iatrogenic hyperchloremic acidosis 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Anion gap acidosis.

Seminars in nephrology, 1998

Research

The anion gap (AG): studies in the nephrotic syndrome and diabetic ketoacidosis (DKA).

The Journal of laboratory and clinical medicine, 2006

Research

Anion gap-bicarbonate relation in diabetic ketoacidosis.

The American journal of medicine, 1986

Research

Hyperchloraemic metabolic acidosis slows recovery in children with diabetic ketoacidosis: a retrospective audit.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses, 2009

Related Questions

What causes an anion gap in Diabetic Ketoacidosis (DKA)?
What is the significance of calculating the anion gap in a patient with Graft-Versus-Host Disease (GVHD) presenting with metabolic acidosis?
What is the appropriate management for a patient presenting with an abnormal anion gap, potentially complicated by underlying conditions such as Diabetes Mellitus or Impaired Renal Function?
What is the initial approach to treating metabolic acidosis with an elevated anion gap?
Are anion gaps still used in the diagnostic workup of Diabetic Ketoacidosis (DKA) according to the new guidelines?
Is colonoscopy safe in a patient with autosomal dominant polycystic kidney disease and an eGFR of 26 mL/min/1.73 m², and what bowel preparation and peri‑procedure precautions are recommended?
What is the appropriate postoperative follow‑up schedule, including history, physical exam, laboratory tests (complete blood count, liver panel, CA 19‑9), and imaging (contrast‑enhanced CT or MRI), for a patient treated for gallbladder cancer?
How should a diaphragmatic (dash) hernia be evaluated and managed?
How should low testosterone be evaluated and managed in a male patient with autosomal dominant polycystic kidney disease and an estimated glomerular filtration rate of 26 mL/min/1.73 m² (CKD stage 4)?
What is the recommended management for an oral ulcer in a post‑transplant patient?
In a 59-year-old woman with persistent dysuria, pyuria and yeast on repeat urinalysis despite a 5‑day course of nitrofurantoin and fluconazole 150 mg, what is the next appropriate management step?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.